Your browser doesn't support javascript.
loading
SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022.
Cheng, Samuel Ms; Mok, Chris Ka Pun; Chan, Karl Ck; Ng, Susanna S; Lam, Bosco Hs; Luk, Leo Lh; Ko, Fanny W; Chen, Chunke; Yiu, Karen; Li, John Kc; Chan, Ken Kp; Tsang, Leo Ch; Poon, Leo Lm; Hui, David Sc; Peiris, Malik.
Afiliación
  • Cheng SM; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Mok CKP; These authors contributed equally to the research.
  • Chan KC; These authors contributed equally to the research.
  • Ng SS; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Lam BH; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Luk LL; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Ko FW; Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Chen C; Department of Pathology, North Lantau Hospital, Hong Kong SAR, China.
  • Yiu K; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Li JK; Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Chan KK; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Tsang LC; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Poon LL; Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Hui DS; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Peiris M; Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Euro Surveill ; 27(18)2022 05.
Article en En | MEDLINE | ID: mdl-35514306
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: China